KLRK1 and neoplasm: This is achieved by recognizing tumor-cell-expressed ligands for the NK cell receptor Natural killer group 2 member D (NKG2D), which are induced by genotoxic stress, the generated inflammation or the transformation process itself (71), or tumor-specific antigens presented by antigen presenting cells (72).